- Home
- Innovation
Innovation
-
Johnson & Johnson and its partners mark a milestone in the quest for a global preventive HIV vaccine with the Imbokodo Study
The clinical trial has completed full immunizations of the company’s investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19. -
“What COVID-19 has taught me": 7 Johnson & Johnson researchers reveal lessons they’ve learned from the pandemic
From scientists working on a potential vaccine to medically trained employees who mobilized to the front lines to help treat patients, these men and women share what most resonates for them about the unique and devastating virus, both professionally and personally. -
Quiz: How much do you really know about COVID-19
Think you are up to speed on the novel coronavirus? Take this quiz to test your virus knowledge. -
She’s a scientist with one of the world’s most important jobs: Creating a potential COVID-19 vaccine
Imagine being a researcher who is staring down not only a highly infectious virus, but one that’s caused the first global pandemic in more than 100 years. Meet Johnson & Johnson’s Hanneke Schuitemaker, Ph.D. -
“I’m racing to screen thousands of molecules": These scientists are canvassing a vast library in search of a potential COVID-19 treatment
Johnson & Johnson has an expansive archive of existing drug compounds—and two researchers are leading the charge in combing through this molecular storehouse in pursuit of a possible breakthrough. -
JLABS @ Washington, DC: The unique innovation hub that’s poised to help protect us from future pandemics
Scientists at the facility, opening in the nation’s capital this year, will be focused on advancing breakthrough ideas for safeguarding people around the world from pandemics like COVID-19, infectious diseases and other health threats. -
Chairman and CEO Alex Gorsky profiled by the Financial Times about Johnson & Johnson’s work on a potential COVID-19 vaccine
The article explores what guided the decision, which is just the latest example of our Chairman and CEO’s people-first approach to leadership at our healthcare company. -
“I’m a scientist working on a potential COVID-19 vaccine”: Meet a researcher who’s studying a promising candidate
Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus. -
“I have never seen a moment so rich in collaboration, ingenuity and acts of bravery": Johnson & Johnson announces it has identified a lead COVID-19 vaccine candidate
Chairman & CEO Alex Gorsky shares that the company could have the first batches of a COVID-19 vaccine available for emergency-use authorization in early 2021—a substantially accelerated time frame in comparison to the typical vaccine development process. -
What it really feels like to have multiple sclerosis
The exact cause of the disease is unknown, but there’s a lot scientists do know about how it impacts nearly every part of the body. Scientists like Tatiana Scherz, M.D., who takes us on a guided journey of how the disease manifests—from your brain down to your toes.